about
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products includ...
Read More
2.76
0.02
(0.73%)
240.2K
XNAS Volume
XNAS 20 Jan, 2026 3:04 PM (EST)
Not Eligible
Expensive Valuation
Technically Bearish
Genelux Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..